DrugMapper


InChI Key	FCSHDIVRCWTZOX-DVTGEIKXSA-N
Smile	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl
InChI	InChI=1S/C22H28ClFO4/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,24)17(26)10-20(16,3)22(12,28)18(27)11-23/h6-7,9,12,15-17,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1

Mesh Heading	Maximum Phase	Mesh ID	Reference
Graft vs Host Disease	3	D006086	ClinicalTrials
Lichen Sclerosus et Atrophicus	3	D018459	ClinicalTrials
Pemphigoid, Bullous	2	D010391	ClinicalTrials
Lichen Planus, Oral	2	D017676	ClinicalTrials
Herpes Labialis	2	D006560	ClinicalTrials
Psoriasis	2	D011565	ClinicalTrials
Bronchiolitis Obliterans Syndrome	2	D000092122	ClinicalTrials
Vulvar Lichen Sclerosus	2	D007724	ClinicalTrials
Stevens-Johnson Syndrome	1	D013262	ClinicalTrials
Phlebitis	1	D010689	ClinicalTrials
Scleroderma, Localized	1	D012594	ClinicalTrials

CLOBETASOL


Active Pharmaceutical Ingredients (APIs) Scaffolds	Exact Similarity SubStructure	Threshold (%) >= 70